• SENSEX 80,242.24
    -46.14 (--0.06%)
  • BANKNIFTY 55,087.15
    -304.10 (--0.55%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Mazagon Dock
    3,149.70 3,149.70(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Cochin Shipyard
    1,575.50 1,169.00(%)
  • Tata Motors
    641.10 542.55(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Torrent Pharma.
    3,300.00 2,513.05(%)
  • Sonata Software
    446.50 762.00(%)
  • Data Pattern
    2,450.00 1,350.50(%)
  • IndusInd Bank
    843.10 1,550.00(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,130.00 4,197.50(%)
  • Varun Beverages
    507.45 419.40(%)
  • ICICI Bank
    1,415.10 1,051.50(%)
  • Vedanta
    423.20 527.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Windlas Biotech Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 36133.0
  • ISIN : INE0H5O01029
965.50 -9 (-0.96%)
  • As on 30 Apr 2025 (EOD)

  • Today’s Low

    958.10

  • Today’s High

    990.50

  • Open

    980.00

  • Perv Close

    974.90

  • 52W Low

    495.65

  • 52W High

    1,198.25

Key Indicators

  • P/E(TTM)

    32.99

  • Mar.Cap (₹Cr.)

    2,017.93

  • Div & Yield %

    0.57

  • Book Value(₹)

    225.63

  • Debt-Equity Ratio

    -0.96

  • AGM Date

    30-Apr-2025

  • EPS

    29.34

  • P/E Ratio

    32.99

Financials Ratios

  • Debt-Equity Ratio

    0.01

  • Mar.Cap (₹Cr.)

    2,017.93

  • RONW (%)

    13.66

  • ROCE (%)

    18.07

Score Board

  • Equity (₹ in Cr.)

    10.45

  • BV (₹)

    225.60

  • Sales( ₹ in Cr.)

    630.96

  • NP (in Cr.)

    58.14

  • NP Var(%)

    38.0

  • Div%

    110.0

  • CPS (₹)

    34.30

  • EPS (₹)

    27.80

  • Traded Value (₹ in Lakhs)

    2,023.05

  • 52 Week High

    1,198.25

  • 52 Week Low

    495.65

  • Price BSE

    968.0

  • Price NSE

    966.00

  • Market Capital( in Cr.)

    2,023.05

  • P/C Ratio

    28.30

  • P/E Ratio

    34.80

  • Price Vs.BV

    27.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 630.96 513.08 465.93 427.60 328.85 288.20
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 630.96 513.08 465.93 427.60 328.85 288.20
Other Income 13.47 9.97 6.71 3.09 0.96 2.12
Stock Adjustments -9.59 15.27 4.74 -3.67 12.75 -3.46
Total Income 634.84 538.32 477.38 427.02 342.56 286.86
EXPENDITURE :            
Raw Materials 386.59 340.71 307.56 270.74 224.35 177.76
Power and Fuel Cost 16.15 12.90 11.01 11.53 8.04 6.22
Employee Cost 87.46 70.32 63.41 58.32 43.88 33.50
Other Manufacturing Expenses 10.52 8.63 8.95 8.37 4.28 3.61
Selling and Administration Expenses 35.92 30.13 23.08 15.09 15.68 15.46
Miscellaneous Expenses 6.63 5.41 3.78 37.54 4.70 3.74
Employee Benefit Expenses 87.46 70.32 63.41 58.32 43.88 33.50
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 543.27 468.10 417.78 401.60 300.93 240.28
Operating Profit 91.57 70.21 59.60 25.44 41.63 46.59
Interest 1.10 0.79 1.42 1.29 2.37 3.64
Gross Profit 90.47 69.42 58.18 24.15 39.26 42.95
Depreciation 13.44 12.36 12.15 12.97 8.69 8.09
Profit Before Tax 77.03 57.06 46.03 11.18 30.57 34.86
Current Tax 17.34 14.35 10.13 4.84 8.24 12.58
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.54 0.06 -2.66 1.33 -0.13 -0.19
Reported Net Profit 58.14 42.64 38.56 5.01 22.46 22.47
Extraordinary Items 0.00 0.65 0.01 -14.49 0.00 0.35
Adjusted Net Profit 58.14 41.99 38.55 19.50 22.46 22.12
Adjustment below Net Profit -0.24 -0.16 -0.18 -26.37 0.00 0.00
P & L Balance brought forward 176.70 141.84 103.46 124.82 98.49 76.02
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 8.32 7.63 0.00 0.00 0.00 0.00
P & L Balance carried down 226.29 176.70 141.84 103.46 120.95 98.49
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 110.00 80.00 70.00 0.00 0.00 0.00
Dividend Per Share(Rs) 5.50 4.00 3.50 0.00 0.00 0.00
Earnings Per Share-Unit Curr 27.96 20.38 17.69 7.81 35.03 35.05
Earnings Per Share(Adj)-Unit Curr 27.96 20.38 17.69 - - -
Book Value 216.51 192.42 181.30 310.39 337.66 302.63
Book Value(Adj)-Unit Curr 216.51 192.42 181.30 - - -

Shareholding Pattern

  • Promoter Group

    62.34%

  • Public Share Holding

    37.66%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,684,012 22.35 4,684,012 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 8,381,340 39.99 8,381,340 1
Others 0 0.00 0 0
Sub Total 13,065,352 62.34 13,065,352 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 318,528 1.52 318,528 26
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,404,918 6.70 1,404,918 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 878,013 4.19 878,013 9
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,601,459 12.41 2,601,459 39
2] Non Institution
Bodies Corporate 381,811 1.82 381,811 161
Clearing Members 346 0.00 346 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 209,243 1.00 209,243 698
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 135,232 0.65 135,232 1,089
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 412,186 1.97 412,186 4
Individuals holding nominal share capital up to Rs. 1 lakh 4,064,690 19.39 4,064,690 44,361
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 93 0.00 93 1
Others 0 0.00 0 0
Sub Total 5,292,500 25.25 5,292,500 46,337
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 20,959,311 100.00 20,959,311 46,383

Company Background

Windlas Biotech LtdPharmaceuticals - Indian - Formulations

  • Windlas Biotech Ltd
  • BSE Code : 36133.0
  • ISIN : INE0H5O01029

  • Incorporation Year

    2001

  • Registered Office

    40/1 Mohabewala Industrial
    Area, Dehradun,
    Uttarakhand-248110

  • Telephone

    91-135-6608000

  • FAX

  • Chairman

    Vivek Dhariwal

  • Managing Director

    Hitesh Windlass

  • Company Secretary

    Ananta Narayan Panda

  • Auditor

    S S Kothari Mehta & Co LLP

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Windlas Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Windlas Biotech 967.95 644.42 630.96 32.99 18.03
Abbott India 29,876.95 6,097.18 5,848.91 47.58 44.71
Astrazeneca Phar 8,665.50 1,330.33 1,295.53 223.40 33.26
P & G Health Ltd 5,072.65 1,166.89 1,151.26 35.59 39.76
Glaxosmi. Pharma 2,959.45 3,530.73 3,407.25 58.85 44.44
Cipla 1,549.65 17,645.00 16,574.34 26.57 20.10
Amrutanjan Healt 692.80 437.58 421.23 40.61 20.84
Guj. Themis Bio. 272.65 174.19 169.82 56.45 44.82
Fermenta Biotec. 260.70 315.24 307.09 24.71 4.10
Bliss GVS Pharma 119.00 638.96 605.46 27.23 11.19
Ambalal Sarabhai 36.46 11.70 3.81 15.58 1.92